Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

333 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-10-31

Study Completion Date

2022-12-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if the drug, Dexmedetomidine (also known as Precedex), can reduce pain for patients having Thoracic Surgery and therefore reduce the amount of opioid drug needed after surgery. It is a drug that is already approved by the FDA (Food \& Drug Administration) for use as a sedative in hospitals and is currently used in the investigators Intensive Care Unit for this purpose. The investigators want to investigate if it also has pain relieving properties.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients

NCT00345384

Post-operative Pain Respiratory Depression

COMPLETED PHASE1/PHASE2

Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery

NCT06502002

Surgery-Complications Respiratory Complication Lung Injury, Acute

COMPLETED NA

Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement

NCT00852046

Sedation Analgesia

WITHDRAWN PHASE4

Dexmedetomidine and Dexamethasone as an Adjuvant to Ropivacaine in Thoracic Surgery

NCT03632460

Pain, Postoperative Oxidative Stress

UNKNOWN NA

Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

NCT06684535

Dexmedetomidine Adjuvant External Oblique Intercostal Plane Block +2 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study involves the use of dexmedetomidine infusion intraoperatively during thoracic surgical procedures (not using an epidural) with discontinuation in the immediate postoperative period. A key feature in this study is to employ the drug infusion intraoperatively only.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dexmedetomidine

continuous infusion of 0.4 mcg/kg/hr

Group Type EXPERIMENTAL

Dexmedetomidine

Intervention Type DRUG

Placebo

continuous infusion of 0.4 mcg/kg/hr

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexmedetomidine

Intervention Type DRUG

Placebo

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients ( ≥ 21 years old) scheduled for Thoracic Surgery

Exclusion Criteria

* 2nd or 3rd degree heart block as assessed by preoperative EKG
* Use of dexmedetomidine within 28 days prior to day of surgery
* Use of long acting opioids pre-operatively 28 days prior to day of surgery
* Current or past diagnosis of a Major Psychiatric disorder precluding adequate outcome responses such as Schizophrenia, dementia, delirium etc. as recorded in the Pre-Operative Record.
* Documentation of congestive heart failure and Ejection fraction \< 30% if recorded in the Pre-Operative Record.
* Planned use of an epidural for surgery or post-operative pain relief
* Contraindication to use of NSAID, Acetaminophen or IV opioids.
* Any known hypersensitivity to dexmedetomidine
* Pregnant or breastfeeding
* Abnormal liver function tests as related to the MSK guidelines for use of IV Acetaminophen

Yes or NO?; Is ALT greater than 2 x Upper Limit of Normal (\> 75 U/L)?

* Abnormal renal function tests as related to contraindications to use of IV Ketorolac

Yes or No?; Is Serum Creatinine \< 1.5 mg/dl?

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No